MedTrace Logo

Evaluation of Blood Loss After Cesarean Delivery Via US Compared to Standard Care

NCT06963047 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 276

Last updated 2026-04-13

No results posted yet for this study

Summary

Postpartum hemorrhage and anemia are considered a major health concern due to their impact on maternal morbidity and mortality, quality of life, and maternal cognitive and emotional functioning after delivery, which are particularly important during the critical period of mother-child bonding. Hemoglobin levels in the first 24 hours after delivery do not reflect the lowest point (nadir). The postpartum nadir occurs 48-72 hours after delivery due to the initial redistribution of plasma volume. The aim of this study was to examine whether postpartum ultrasound examination precedes laboratory test results in the diagnosis of anemia due to blood loss after cesarean section.

Conditions

  • Postpartum Period

Interventions

DIAGNOSTIC_TEST

Ultrasound

The purpose of the test is to diagnose and assess the amount of blood loss.

OTHER

Standard care

Routine management

Sponsors & Collaborators

  • Holy Family Hospital, Nazareth, Israel

    lead OTHER

Principal Investigators

  • Raed Salim, MD · Holy Family Hospital, Nazareth, Israel

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-08
Primary Completion
2026-05-01
Completion
2026-06-01

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06963047 on ClinicalTrials.gov